| 717728 |
FRONTIERS IN ONCOLOGY |
Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells |
2021-07-20 |
10.3389/fonc.2021.683688 |
Hintelmann Katharina, Berenz Thomas, Kriegs Malte, Christiansen Sabrina, Gatzemeier Fruzsina, Struve Nina, Petersen Cordula, Betz Christian, Rothkamm Kai, Oetting Agnes, Rieckmann Thorsten |
| 717727 |
FRONTIERS IN ONCOLOGY |
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma |
2021-07-20 |
10.3389/fonc.2021.705948 |
Capoluongo Ettore, Nardelli Carmela, Esposito Maria Valeria, Buonomo Antonio Riccardo, Gelzo Monica, Pinchera Biagio, Zappulo Emanuela, Viceconte Giulio, Portella Giuseppe, Setaro Mario, Gentile Ivan, Castaldo Giuseppe |
| 717726 |
FRONTIERS IN ONCOLOGY |
Identification of the Extradural and Intradural Extension of Pituitary Adenomas to the Suprasellar Region: Classification, Surgical Strategies, and Outcomes |
2021-07-20 |
10.3389/fonc.2021.723513 |
Yang YouQing, Bao YouYuan, Xie ShenHao, Tang Bin, Wu Xiao, Yang Le, Wu Jie, Ding Han, Li ShaoYang, Zheng SuYue, Hong Tao |
| 717725 |
FRONTIERS IN ONCOLOGY |
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment |
2021-07-20 |
10.3389/fonc.2021.702642 |
Gaggianesi Miriam, Di Franco Simone, Pantina Vincenzo Davide, Porcelli Gaetana, D'Accardo Caterina, Verona Francesco, Veschi Veronica, Colarossi Lorenzo, Faldetta Naida, Pistone Giuseppe, Bongiorno Maria Rita, Todaro Matilde, Stassi Giorgio |
| 717724 |
FRONTIERS IN ONCOLOGY |
Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients |
2021-07-20 |
10.3389/fonc.2021.678315 |
Lusho Sejdi, Durando Xavier, Mouret-Reynier Marie-Ange, Kossai Myriam, Lacrampe Nathalie, Molnar Ioana, Penault-Llorca Frederique, Radosevic-Robin Nina, Abrial Catherine |
| 717723 |
FRONTIERS IN ONCOLOGY |
What Does Quality of Care Mean in Lower-Grade Glioma Patients: A Precision Molecular-Based Management of the Tumor or an Individualized Medicine Centered on Patient’s Choices? |
2021-07-20 |
10.3389/fonc.2021.719014 |
Taillandier Luc, Obara Tiphaine, Duffau Hugues |
| 717722 |
FRONTIERS IN ONCOLOGY |
Commentary: Identification of IFN-Induced Transmembrane Protein 1 With Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis |
2021-07-20 |
10.3389/fonc.2021.707516 |
Li Xinxiao, Liang Renba, Yang Liu |
| 717721 |
FRONTIERS IN ONCOLOGY |
Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy? |
2021-07-20 |
10.3389/fonc.2021.715297 |
Lübbers Katharina, Pavlychenko Mykola, Wald Theresa, Wiegand Susanne, Dietz Andreas, Zebralla Veit, Wichmann Gunnar |
| 717720 |
FRONTIERS IN ONCOLOGY |
DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation |
2021-07-20 |
10.3389/fonc.2021.706337 |
Su Zhenzi, Gao Aidi, Li Xiaoqing, Zou Shitao, He Chao, Wu Jinchang, Ding Wei-Qun, Zhou Jundong |
| 717719 |
FRONTIERS IN ONCOLOGY |
Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population |
2021-07-20 |
10.3389/fonc.2021.699577 |
Pinheiro Paulo S., Medina Heidy N., Koru-Sengul Tulay, Qiao Baozhen, Schymura Maria, Kobetz Erin N., Schlumbrecht Matthew P. |
